What is the rationale for disciplined surveillance systems for FD patients with either asymptomatic CV or those in whom the diagnosis has been confirmed?

What is the rationale for disciplined surveillance systems for FD patients with either asymptomatic CV or those in whom the diagnosis has been confirmed?

What is the rationale for disciplined surveillance systems for FD patients with either asymptomatic CV or those in whom the diagnosis has been confirmed? And what evidence do we have that chaperone therapy or RT can slow progression of either myocardial dysfunction or frequency of arrhythmias?


Created by

CMEducation Resources IQ&A Fabry Disease Diagnostic Intelligence Zone

Presenter

John Jefferies, MD

John Jefferies, MD

Jay M. Sullivan Endowed Chair in Cardiovascular Medicine
Chief of Cardiology
University of Tennessee Health Science Center (UTHSC)
Co-Director, UT Methodist Institute for Cardiovascular Science
University of Tennessee Heart Institute
Memphis, TN